NVO Stock Recent News

NVO LATEST HEADLINES

NVO Stock News Image - fool.com

There is a long-running health crisis impacting the modern world. According to the World Health Organization, one in eight people worldwide were living with obesity as of 2022.

fool.com 2025 Mar 26
NVO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=138645&wire=1 or contact Joseph E. Levi, Esq.

accessnewswire.com 2025 Mar 25
NVO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=138604&wire=1 or contact Joseph E. Levi, Esq.

accessnewswire.com 2025 Mar 25
NVO Stock News Image - zacks.com

NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.

zacks.com 2025 Mar 25
NVO Stock News Image - cnbc.com

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors' perception of the health care system is improving.

cnbc.com 2025 Mar 25
NVO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=138573&wire=1 or contact Joseph E. Levi, Esq.

accessnewswire.com 2025 Mar 25
NVO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period"), of the important March 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

accessnewswire.com 2025 Mar 25
NVO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=138555&wire=1 or contact Joseph E. Levi, Esq.

accessnewswire.com 2025 Mar 25
NVO Stock News Image - zacks.com

Industry Description

zacks.com 2025 Mar 25
NVO Stock News Image - accessnewswire.com

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=138425&wire=1 or contact Joseph E. Levi, Esq.

accessnewswire.com 2025 Mar 24
10 of 50